Guardant Health
GH
#1463
Rank
C$20.63 B
Marketcap
C$158.88
Share price
2.43%
Change (1 day)
146.15%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2025 (TTM): -C$0.56 Billion

According to Guardant Health 's latest financial reports the company's current earnings are C$0.90 Billion. In 2024 the company made an earning of -C$0.61 Billion, an increase over its 2023 earnings that were of -C$0.67 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$0.56 Billion-7.02%
2024 -C$0.61 Billion-9.12%
2023 -C$0.67 Billion-26.73%
2022 -C$0.91 Billion69.96%
2021 -C$0.54 Billion56.35%
2020 -C$0.35 Billion252.69%
2019 -C$96.44 Million-17.22%
2018 -C$0.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Natera
NTRA
-C$0.43 Billion-22.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
-C$0.86 Billion 55.30%๐Ÿ‡บ๐Ÿ‡ธ USA